We scan new podcasts and send you the top 5 insights daily.
Florent says complaints, adverse events, field service and repairs are continuous signals from the field. Most medical device companies only collect that data; the missing piece is recognizing signals from noise and taking action. That gap makes recalls look like visibility failures, not just isolated engineering failures.
Florent describes the ideal complaint check: match the issue to a hazard in the risk file, find the acceptable failure rate, count similar events over 12 months, then divide by sales or install base. Nobody does this because gathering and correlating the data is too much work; Smartiva's AI does it in real time.
Florent gives a risk file as the example: pre-market teams build it for approval, and post-market teams could compare real-world complaints against it, including acceptable failure rates. But in most companies the pre-market and post-market groups and their data do not talk to each other.
Beyond customer support, the Genius Bar was an invaluable intelligence-gathering tool for Apple's engineers. It provided immediate, high-volume feedback on product flaws post-launch, as seen with the iPhone 4's "Antenna Gate," enabling rapid diagnosis and solutions directly from the user front lines.
When customers blame your product for external failures you can't control (e.g., an SMS isn't delivered), don't dismiss the feedback. This often signals a need for better error handling or resilience. Use it as a prompt to build fallback mechanisms or better user notifications, thereby improving the overall experience.
In high-stakes regulated fields, documentation like FMEAs is not red tape. It's a critical tool for understanding failure modes, mitigating risks, and ensuring product viability and patient safety, especially for a startup where one recall can be fatal.
Florent says an MDR contains registration, product and event information that already exists; only the manufacturer response and event description need careful judgment. Smartiva demonstrated a three-minute AI-assisted MDR submission so customers can spend time on patient safety and product improvement instead of filling out forms.
Implementing technology is just the start. Most healthcare organizations fail by abandoning projects post-launch. True adoption requires a continuous feedback loop with end-users like doctors and nurses to evaluate use cases, identify pain points, and iteratively improve the solution.
Florent says post-market surveillance falls between customer service, quality and regulatory but is not exactly any of them. Complaints contain heavy customer-service work and needs that a typical quality management system does not cover, at larger volumes and complexity. That gap kept the space underinvested and led him to start Smartiva.
Strong data from controlled trials will open doors, but it won't guarantee broad adoption. True success comes from a product's predictable, reliable performance in everyday clinical settings, which are far more chaotic than an investigational site.
The 'fail fast' ethos isn't just for startups. Dr. Arthur explains how Medtronic applied this principle by being transparent about the Pipeline Vantage recall. This honesty is key to making progress and turning a failure into a driver for a better product.